T. Boone Pickens’s Latest Energy Plays: Occidental Petroleum Corporation (OXY), Marathon Oil Corporation (MRO)

Page 1 of 2

Hedge fund sentiment is a metric that is underrated by retail investors, and our research shows that these money managers’ consensus picks can beat the market by a significant margin (see the details of our market-beating strategy). Of the 450-plus hedge fund managers we track at Insider Monkey, T. Boone Pickens is in the upper echelon, and one unique aspect of his fund, BP Capital, is that it holds a very concentrated equity portfolio.

At the end of the fourth quarter—the latest 13F filing period from the SEC—Pickens reported holding a little over $100 million in 19 different stocks. Let’s take a look at the hedge fund manager’s key moves over this period.

Meet the new “fab four”

T Boone PickensWe’re used to seeing a moderate level of quarterly turnover in Pickens’s portfolio, and Q4 was no different. BP Capital reported new stakes in Weatherford International Ltd (NYSE:WFT), Occidental Petroleum Corporation (NYSE:OXY), Newfield Exploration Co. (NYSE:NFX), and Marathon Oil Corporation (NYSE:MRO). The hedge fund’s total exposure to these stocks represented close to one-fifth of its entire equity portfolio at the end of Q4, and each is in the green in 2013 thus far.

Weatherford gives Pickens exposure to the oilwell services space on a global scale, and Occidental, Newfield and Marathon cover the oil and gas E&P industry in its entirety. Marathon’s presence in the oil sands segment is an added bonus, and it, along with Occidental, offers a dividend yield in excess of 1.9%. While Marathon seems like the best value of this four, it wouldn’t be a bad bet for “monkeys” to consider this group in tandem, as Pickens has demonstrated.

Range, National Oilwell Varco bull

In addition to these new positions, Pickens and BP Capital also upped their holdings in Range Resources Corp. (NYSE:RRC) and National Oilwell Varco, Inc. (NYSE:NOV) by 63.2% and 287.4% respectively.

What does Wall Street think about this duo?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!